Pten Hamartoma Tumor Syndrome
📧 Sign up to get email alerts when something new happens for Pten Hamartoma Tumor Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: Web Intervention for Parents of Youth With Genetic Syndromes (WINGS) [NA]
Rush University Medical Center is conducting a web-based intervention (WINGS) for parents of youths with several genetic syndromes, and the …
-
CLINICAL_TRIALS trial_result · 2026-01-06Clinical Trial Update: Safety and Efficacy Study of Sirolimus in Complicated Vascular Anomalies [Phase 2]
Phase 2 trial evaluating sirolimus for safety and efficacy in complicated vascular anomalies has completed. Results were posted on 2026-01-0…
-
CLINICAL_TRIALS research · 2025-12-04Clinical Trial Update: PTEN Hamartoma Tumor Syndrome Pediatric Patient Registry
A pediatric patient registry for PTEN hamartoma tumor syndrome is currently recruiting, sponsored by Yale University, as noted in ClinicalTr…
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: Cancer Risk Assessment in Patients With a Constitutional Alteration of the PTEN Gene
A clinical trial sponsored by Institut Bergonié is evaluating cancer risk assessment in individuals with constitutional PTEN gene alteration…
-
CLINICAL_TRIALS research · 2025-10-20Clinical Trial Update: Double-Blind Trial of Everolimus for Improving Social Abilities in PTEN Germline Mutations [Phase 2, Phase 3]
A double-blind trial of everolimus to improve social abilities in individuals with PTEN germline mutations. The study includes Cowden syndro…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-06-10Clinical Trial Update: Sirolimus for Cowden Syndrome With Colon Polyposis [Phase 2]
Phase 2 clinical trial of sirolimus for Cowden syndrome with colon polyposis has completed, sponsored by Ohio State University. The study ta…
-
CLINICAL_TRIALS trial_result · 2025-02-17Clinical Trial Update: RAD001 and Neurocognition in PTEN Hamartoma Tumor Syndrome [Phase 1, Phase 2]
This clinical trial update reports results from Phase 1 and Phase 2 studies of everolimus (RAD001) for neurocognition in individuals with PT…
-
CLINICAL_TRIALS research · 2024-10-26Clinical Trial Update: Natural History Study of Individuals With Autism and Germline Heterozygous PTEN Mutations
A natural history study of individuals with autism who have germline heterozygous PTEN mutations is currently recruiting, led by Boston Chil…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Development and Validation of an Online Neurobehavioral Evaluation Tool for PTEN Patients
A completed clinical trial evaluating and validating an online neurobehavioral evaluation tool for individuals with PTEN Hamartoma Tumor Syn…
-
CLINICAL_TRIALS withdrawal · 2024-07-10Clinical Trial Update: Sirolimus for Improving Social Abilities in People With PTEN Germline Mutations [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating sirolimus for improving social abilities in people with PTEN germline mutations has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2013-07-19Clinical Trial Update: Sirolimus to Treat Cowden Syndrome and Other PTEN Hamartomatous Tumor Syndromes [Phase 2]
A Phase 2 trial evaluated sirolimus for Cowden syndrome and related PTEN hamartoma tumor syndromes and has completed with results posted in …